Autolus Therapeutics (AUTL) Other Non Operating Income (2017 - 2025)

Autolus Therapeutics (AUTL) has 9 years of Other Non Operating Income data on file, last reported at $363000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Non Operating Income rose 131.27% year-over-year to $363000.0; the trailing twelve-month figure through Dec 2025 stood at $787000.0 (up 106.48% YoY), and the FY2025 full-year result was $2.2 million, up 316.3% from the prior year.
• Other Non Operating Income for Q4 2025 stood at $363000.0, up from -$911000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $951.0 million in Q3 2021 and bottomed at -$11.9 million in Q3 2024.
• The 5-year median for Other Non Operating Income is $135000.0 (2025), against an average of $49.6 million.
• The widest annual swing landed in 2021, when Other Non Operating Income jumped 38003.55%; it then tumbled 599.06% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at -$86000.0 in 2021, then jumped by 7369.77% to $6.3 million in 2022, then slumped by 60.16% to $2.5 million in 2023, then sank by 146.61% to -$1.2 million in 2024, then jumped by 131.27% to $363000.0 in 2025.
• The last three Other Non Operating Income figures came in at $363000.0 (Q4 2025), -$911000.0 (Q3 2025), and $135000.0 (Q2 2025), per Business Quant data.

Peer Comparison